322
Views
7
CrossRef citations to date
0
Altmetric
Articles

Polyethylenimine-graft-poly (maleic anhydride-alt-1-octadecene) coated Fe3O4 magnetic nanoparticles: promising targeted pH-sensitive system for curcumin delivery and MR imaging

, ORCID Icon, , , , & show all
Pages 1344-1353 | Received 06 Apr 2020, Accepted 06 Jul 2020, Published online: 04 Aug 2020
 

Abstract

A theranostic amphiphilic nanocarrier based on iron oxide core with polyethyleneimine and poly(maleic anhydride-alt-1-octadecene) shell was synthesized, labeled with folic acid and loaded with Curcumin. Fe3O4@PIMF nanoparticles displayed a size of 20–30 nm with a shell thickness of 2–5 nm. Fe3O4@PIMF-CUR MNPs exhibited pH-responsive release behavior matched with Michaelis–Menten model. The MNPs showed more toxicity than free CUR against MCF-7 and Hela cells, while the drug-free carrier was safe against both cell lines. Hemolytic activity less than 1.5% in concentrations of <500 µg/mL indicated excellent blood compatibility. Appropriate negative signal enhancement in MRI confirmed the efficiency of the system for cancer theranostics.

Graphical Abstract

Disclosure statement

The authors of this manuscript do not have any financial conflict of interest.

Additional information

Funding

This work was supported by a grant from National Institute for Medical Research Development (NIMAD, grant number: 982891).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.